Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

91
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
91
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

86
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
86
Positron Emission Tomography01:29

Positron Emission Tomography

4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced pre-therapy dosimetry for SSTR PET: A head-to-head preclinical assessment of [<sup>89</sup>Zr]Zr-DFO-TOC and [<sup>89</sup>Zr]Zr-DFO-TATE.

Nuclear medicine and biology·2026
Same author

Dosimetric and biological impact of activity extravasation of radiopharmaceuticals in PET imaging.

Medical physics·2024
Same author

Insights into handling and delivery of Y-90 radioembolization therapies.

Frontiers in nuclear medicine·2024
Same author

Mucinous-appearing contamination of serous effusions by sodium carboxymethyl cellulose from suction canister lids.

Cancer cytopathology·2024
Same author

Data-driven head motion correction for PET using time-of-flight and positron emission particle tracking techniques.

PloS one·2022
Same author

Guidelines on Setting Up Stations for Remote Viewing of Nuclear Medicine and Molecular Imaging Studies During COVID-19.

Journal of nuclear medicine technology·2020

Related Experiment Video

Updated: Jun 11, 2025

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

314

Radiopharmaceutical extravasations: a twenty year mini-review.

Dustin R Osborne1

  • 1Department of Radiology, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.

Frontiers in Nuclear Medicine
|October 9, 2024
PubMed
Summary

Radiopharmaceutical extravasation research is growing due to increased use of these therapies and novel imaging agents. This review summarizes historical trends, identifies research gaps, and promotes innovation in theranostic radiopharmaceuticals.

Keywords:
extravasationmolecular imagingradiopharmaceutical therapyradiopharmaceuticalstheranostics

More Related Videos

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

14.5K

Related Experiment Videos

Last Updated: Jun 11, 2025

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

314
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

14.5K

Area of Science:

  • Nuclear medicine and radiopharmacy.
  • Molecular imaging and targeted therapy.

Background:

  • Increasing use of radiopharmaceutical therapies and novel molecular imaging agents has spurred interest in extravasation.
  • Recent regulatory controversies highlight the need for better understanding of radiopharmaceutical extravasation.

Purpose of the Study:

  • To review the literature on radiopharmaceutical extravasation over the past twenty years.
  • To summarize the history, identify trends in imaging and therapies, and highlight research gaps.
  • To promote awareness and innovation in theranostic radiopharmaceutical extravasation.

Main Methods:

  • Comprehensive literature review of scientific articles and regulatory documents from the last two decades.
  • Analysis of trends in radiopharmaceutical therapy applications and molecular imaging techniques.
  • Identification of knowledge gaps and areas for future research.

Main Results:

  • The incidence and impact of radiopharmaceutical extravasation have become more prominent.
  • Significant advancements in molecular imaging have aided in the detection and management of extravasation.
  • Therapeutic strategies for managing extravasation are evolving, but gaps remain.

Conclusions:

  • Radiopharmaceutical extravasation is a critical consideration in theranostic applications.
  • Further research is needed to optimize management strategies and minimize patient risk.
  • Enhanced understanding and standardized protocols are essential for safe and effective radiopharmaceutical use.